evaluation of a thyroid nodule by vijay
DESCRIPTION
EVALUATION OF A THYROID NODULETRANSCRIPT
![Page 1: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/1.jpg)
EVALUATION OF A THYROID NODULE
VIJAY SHEWALEKIMS , TRIVANDRUM14TH AUG 2013
![Page 2: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/2.jpg)
INTRODUCTION
• DEFINITION- A discrete lesion within the thyroid gland that is palpably and/or radiologically distinct from surrounding thyroid parenchyma.
![Page 3: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/3.jpg)
INTRODUCTION
• PREVALENCE- Epidemiological studies have shown that prevalence of palpable thyroid nodule is 5% in women and 1% in men. This prevalence increases upto 19 – 67 % if detected by ultrasound.
• Nodular goitre prevalence increases by age
![Page 4: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/4.jpg)
![Page 5: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/5.jpg)
INTRODUCTION
• The importance of thyroid nodule rests with the need to exclude thyroid malignancy which occurs in 5 – 15 %
![Page 6: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/6.jpg)
HOW WAS THE NODULE FOUND
• Palpation with a physical exam• Incidental finding on diagnostic work up• Self detection• Surveillance • Work up for symptoms of hyper or
hypothyroidism
![Page 7: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/7.jpg)
CLINICAL EVALUATION
![Page 8: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/8.jpg)
HISTORY
• Age , sex• Swelling in front or side of a neck• h/o pain• Sudden increase in size• Pressure symptoms such as hoarseness of
voice , dyspnoea , dysphagia (rarely)
![Page 9: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/9.jpg)
HISTORY
• h/o hyperthyroid – loss of weight in spite of good appetite, intolerance to heat, excessive sweating
CNS symptoms like- irritability , insomnia, tremor of hands, muscle weakness EYE symptoms such as staring look, difficulty in closing eye, double visionCNS and EYE symptoms are s/o primary
![Page 10: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/10.jpg)
HISTORY
CVS symptoms like palpitations , chest pain , dyspnoea on exertion are s/o secondary hyperthyroid• h/o hypothyroid- increase in weight in spite of
poor appetite, facial puffiness, loss of hair, lethargy, poor memory, constipation, oligomenorrhoea
![Page 11: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/11.jpg)
HISTORY
PAST HISTORY• h/o neck irradiation , • h/o thyroid disease in family
![Page 12: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/12.jpg)
EXAMINATION
General examination-Signs of hyperthyroid- tachycardia, tremor, moist skin, eye signs like exophthalmos look, Von Graefe’s sign, lid retraction, joffroy’s sign,stellwag’s sign, moebius sign
![Page 13: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/13.jpg)
EXAMINATION
Local examination-• Movement of swelling with deglutition• Size , consistency of nodule• Tracheal deviation, retrosternal extension• Cervical lymphadenopathy
![Page 14: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/14.jpg)
WORK UP
![Page 15: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/15.jpg)
THE AMERICAN THYROID ASSOCIATION (ATA) GUIDELINES FOR THYROID NODULE
2009 , REVISED IN 2013
![Page 16: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/16.jpg)
![Page 17: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/17.jpg)
SERUM TSH
• Low TSH may be associated with functioning nodule, very unlikely to be malignant
• TSH has trophic effect on thyroid cancer growth mediated by TSH receptors on tumor cells
• TSH suppression is an independent predictor for relapse free survival in differentiated thyroid cancer
![Page 18: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/18.jpg)
![Page 19: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/19.jpg)
ULTRASOUND SCAN
Can answer following questions• Solid/cystic• size• Additional nodule• Benign or malignant feature
![Page 20: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/20.jpg)
ULTRASOUND SCAN
BENIGN• Iso / hyper echoic• Coarse calcifications• Thin, well defined halo• Regular margins• Hypovascular• No lymph nodes
MALIGNANT• Hypo echoic• Micro calcifications• Thick or absent halo• Irregular margins• Hypervascular• Lymphadenopathy• Taller than wide lesion
![Page 21: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/21.jpg)
HYPOECHOIC
![Page 22: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/22.jpg)
HYPERVASCULARITY
![Page 23: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/23.jpg)
CALCIFICATIONS, POORLY DEFINED, IRREGULAR MARGINS
![Page 24: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/24.jpg)
SOLID
![Page 25: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/25.jpg)
Is size predictor of malignancy
• Non palpable nodules have the same risk of malignancy as palpable nodules with the same size
• Generally, only nodules >1 cm should be evaluated, since they have a greater potential to be clinically significant cancers.
• Nodules <1 cm that require evaluation because of suspicious US findings, associated lymphadenopathy, a history of head and neck irradiation, or a history of thyroid cancer in one or more first-degree relatives.
![Page 26: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/26.jpg)
• Nodules <1 cm lack these warning signs yet eventually cause morbidity and mortality. These are rare and, given unfavourable cost/benefit considerations, attempts to diagnose and treat all small thyroid cancers in an effort to prevent these rare outcomes would likely cause more harm than good.
![Page 27: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/27.jpg)
FNAC
• Only gold standard test for proof of malignancy without surgical pathology
• 23 – 25 gauze no needle is used
![Page 28: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/28.jpg)
INDICATIONS FOR US GUIDED FNAC
• Non palpable or difficult to palpate nodule• Previous non diagnostic cytology• Nodules with previous benign cytology which
has grown in size
![Page 29: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/29.jpg)
FNAC RESULTS
• Nondiagnostic (thy 1)• Benign(thy2)• Suspicious for a Follicular Neoplasm/Follicular
Neoplasm(thy3)• Suspicious for Malignancy(thy4)• Malignant(thy5)
![Page 30: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/30.jpg)
BENIGN
• Scanty normal follicular cells together with colloid
![Page 31: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/31.jpg)
PAPILLARY
• Nuclear grroving• Papillary projections• Orphan annie eye nuclei
![Page 32: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/32.jpg)
FOLLICULAR
• Increased cellularity with a follicular pattern
![Page 33: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/33.jpg)
HURTHLE CELL
• Variant of follicular neoplasm• Oxyphill ( askanazy ) cells predominate
![Page 34: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/34.jpg)
MEDULLARY
• Amyloid stroma
![Page 35: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/35.jpg)
NON DIAGNOSTIC CYTOLOGY
• In persistent non diagnostic cytology risk of malignancy is less than 5%
• Surgery should be considered if nodule is solid
![Page 36: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/36.jpg)
BENIGN CYTOLOGY
• TSH suppressive dose of thyroxine is not recommended
• Repeat us guided evaluation after 6 months• If size same or decrease, continue to follow up
for longer intervals• If increasing us guided cytology• Surgery is recommended in recurrent cystic
nodule with benign cytology
![Page 37: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/37.jpg)
FOLLICULAR NEOPLASM
• I 123 thyroid scan should be considered if serum TSH is in low normal level
• Surgery should be consider if no concurrent hyperfunctioning nodule is present
• Total thyroidectomy if nodule > 4 cm in size bilobar nodular disease h/o radiation exposure or family h/o thyroid malignancy
![Page 38: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/38.jpg)
FOLLICULAR NEOPLASM
• Use of molecular markers such as BRAF, RET/PTC, Ras, PAX8/PPARy or GALECTIN3 may be consider
![Page 39: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/39.jpg)
PAPILLARY
• Total thyroidectomy unless if nodule is less than 1 cm and unifocal
• Modified radical neck dissection only if enlarged lymph nodes are present
![Page 40: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/40.jpg)
MEDULLARY
• Total thyroidectomy• Central compartment lymph node dissection is
recommended• Modified radical neck dissection only if
enlarged lymph nodes are present
![Page 41: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/41.jpg)
ANAPLASTIC
• Total thyroidectomy• Prognosis is poor
![Page 42: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/42.jpg)
LYMPHOMA
• Chemotherapy• Surgery indicated if pressure symptoms are
present
![Page 43: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/43.jpg)
![Page 44: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/44.jpg)
THYROID SCAN
• Only in hyperthyroid• In hot nodule, surgery is recommended after
preparation• In cold nodule ,10 % possibility of malignancy. FNAC is advised, manage accordingly
![Page 45: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/45.jpg)
POST OPERATIVE MANAGEMENT
• In DTC , patient are categorized in high or low risk for recurrence
• AMES (lahey clinic)- age , metastasis, extension , size
• AGES (mayo clinic 1987)- age , grade, extension, size
• MACIS (mayo clinic 1993)- metastasis, age , completeness of resection , invasion, size
![Page 46: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/46.jpg)
POST OPERATIVE MANAGEMENT
• GAMES (MSKCC)- grade , age , metastasis, extension, size
• TNMFOR DTCAge < 45Stage 1 – any T, any N, M0Stage2 - any T ,any N , M1
![Page 47: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/47.jpg)
POST OPERATIVE MANAGEMENT
Age > 45 in DTC and medullaryStage 1 – T1 N0 M0Stage 2- T2 N0 M0Stage 3- T 3 N0 M0 or T 1-3 N1 M0Stage 4A- T4aStage 4 B – T4bStage 4 C – M1
![Page 48: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/48.jpg)
POST OPERATIVE MANAGEMENT
• ANAPLASTICStage 4 A- T 4aStage 4B- T4bStage 4C- T 4c
![Page 49: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/49.jpg)
POST OPERATIVE MANAGEMNT
• In differentiated thyroid carcinoma - Iodine 131 ablation to remove any residual thyroid tissue and malignant cells, to allow follow up with serum thyroglobulin
• Radioiodine scan, serum thyroglobulin, ultrasound scan , to monitor the patients for recurrence
![Page 50: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/50.jpg)
POST OPERATIVE MANAGEMENT
• In medullary ca- radiotherapy recommended if lymph nodes are positive for metastasis
• Tyrosine kinase inhibitors, VEGF receptor inhibitors are under trial now
• Follow up with serum calcitonin , and CEA
![Page 51: Evaluation of a thyroid nodule by vijay](https://reader035.vdocuments.us/reader035/viewer/2022062513/55654e96d8b42a77078b47a6/html5/thumbnails/51.jpg)
THANK YOU